D. Genini et al., Nucleotide requirements for the in vitro activation of the apoptosis protein-activating factor-1-mediated caspase pathway, J BIOL CHEM, 275(1), 2000, pp. 29-34
Adenine deoxynucleosides, such as 2-chloradeoxyadenosine (2CdA) and fludara
bine, induce apoptosis in quiescent lymphocytes, and are thus useful drugs
for the treatment of indolent lymphoproliferative diseases, We previously d
emonstrated that that the 5'-triphosphate metabolite of 2CdA (2CdATP), simi
lar to dATP, can co-operate with cytochrome c and apoptosis protein-activat
ing factor-1 (APAF-1) to trigger a caspase pathway in a HeLa cell-free syst
em. We used a fluorometry-based assay of caspase activation to extend the a
nalysis to several other clinically relevant adenine deoxynucleotides in B-
chronic lymphocytic leukemia extracts. The nucleotide-induced caspase activ
ation displayed typical Michaelis-Menten kinetics. As estimated by the V-ma
x/K-m ratios, the relative efficiencies of different nucleotides were Ara-A
TP > 9-fluoro-9-beta-D-arabinofuranosyladenine 5'-triphosphate > dATP > SCd
ATP > 9-beta-D-arabinofuranosylguanine 5'-triphosphate > dADP > ATP. In con
trast to dADP, both ADP and its nonhydrolyzable alpha,beta-methylphosphonat
e analog were strong inhibitors of APAF-1-dependent caspase activation. The
hierarchy of nucleotide activation was confirmed in a fully reconstituted
system using recombinant APAF-1 and recombinant procaspase-9. These results
suggest that the potency of adenine deoxynucleotides as co-factors for APA
F-1-dependent caspase activation is due bath to stimulation by the 5'-triph
osphates and lack of inhibition by the 5'-diphosphates, The capacity of ade
nine deoxynucleoside metabolites to activate the apoptosome pathway may be
an additional biochemical mechanism that plays a role in the chemotherapy o
f indolent lymphoproliferative diseases.